Results 231 to 240 of about 1,214,228 (245)

Immunomodulatory properties of antihypertensive drugs and digitalis glycosides

Expert Review of Cardiovascular Therapy, 2022
Janusz Marcinkiewicz, Paweł Bryniarski, Katarzyna Nazimek   +2 more
exaly  

Immunomodulatory drugs in multiple myeloma

Expert Review of Hematology, 2013
Vivek Roy
exaly  

High dose hepatitis B vaccine is not effective in patients using immunomodulatory drugs: a pilot study

Human Vaccines and Immunotherapeutics, 2019
Fatma Eser, Aslı Haykır Solay
exaly  

Efficient Synthesis of Immunomodulatory Drug Analogues Enables Exploration of Structure–Degradation Relationships

ChemMedChem, 2018
Philipp M Cromm, Saul Jaime-Figueroa, George M. Burslem   +2 more
exaly  

Therapeutic use of immunomodulatory drugs in the treatment of multiple myeloma

Expert Review of Anticancer Therapy, 2006
Noopur Raje
exaly  

Immunomodulatory drugs for multiple sclerosis: a systematic review of clinical and cost effectiveness

Expert Opinion on Pharmacotherapy, 2001
Andrew Clegg, Jackie Bryant, J Bryant
exaly  

Recent clinical studies of the immunomodulatory drug (IMiD®) lenalidomide

British Journal of Cancer, 2005
J B Zeldis, D Stirling
exaly  

Immunomodulatory drugs in multiple myeloma: from molecular mechanisms of action to clinical practice

Immunopharmacology and Immunotoxicology, 2012
Agostino Cortelezzi, Fabio Conforti, Roberto Castelli   +2 more
exaly  

Mechanisms of Thrombosis in Paraproteinemias: The Effects of Immunomodulatory Drugs

Seminars in Thrombosis and Hemostasis, 2012
Fenghuang Zhan, Maurizio Zangari, Tamara Berno   +2 more
exaly  

Establishing the Carcinogenic Risk of Immunomodulatory Drugs

Toxicologic Pathology, 2012
James L Weaver
exaly